Literature DB >> 18456730

Sex differences in circulating and renal angiotensins of hypertensive mRen(2). Lewis but not normotensive Lewis rats.

Karl D Pendergrass1, Nancy T Pirro, Brian M Westwood, Carlos M Ferrario, K Bridget Brosnihan, Mark C Chappell.   

Abstract

Sex differences in blood pressure are evident in experimental models and human subjects, yet the mechanisms underlying this disparity remain equivocal. The current study sought to define the extent of male-female differences in the circulating and tissue renin-angiotensin aldosterone systems (RAASs) of congenic mRen(2). Lewis and control Lewis rats. Male congenics exhibited higher systolic blood pressure than females [200 +/- 4 vs. 146 +/- 7 mmHg, P < 0.01] or Lewis males and females [113 +/- 2 vs. 112 +/- 2 mmHg, P > 0.05]. Plasma ANG II levels were twofold higher in male congenics [47 +/- 3 vs. 19 +/- 3 pM, P < 0.01] and fivefold higher than in male or female Lewis rats [6 +/- 1 vs. 6 +/- 1 pM]. ANG I levels were also highest in the males; however, plasma ANG-(1-7) was higher in female congenics. Male congenics exhibited greater circulating renin and angiotensin-converting enzyme (ACE) activities, as well as angiotensinogen, than female littermates. Renal cortical and medullary ANG II levels were also higher in the male congenics versus all the other groups; ANG I was lower in the males. Cortical ACE2 activity was higher in male congenics, yet neprilysin activity and protein were greater in the females, which may contribute to reduced renal levels of ANG II. These data reveal that sex differences in both the circulating and renal RAAS are apparent primarily in the hypertensive group. The enhanced activity of the RAAS in male congenics may contribute to the higher pressure and tissue injury evident in the strain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18456730      PMCID: PMC2494740          DOI: 10.1152/ajpheart.01277.2007

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  64 in total

1.  Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan.

Authors:  S N Iyer; M C Chappell; D B Averill; D I Diz; C M Ferrario
Journal:  Hypertension       Date:  1998-02       Impact factor: 10.190

2.  Effects of ovariectomy and estrogen replacement on aorta angiotensin-converting enzyme activity in rats.

Authors:  M Tanaka; S Nakaya; M Watanabe; T Kumai; T Tateishi; S Kobayashi
Journal:  Jpn J Pharmacol       Date:  1997-04

3.  Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme.

Authors:  M C Chappell; N T Pirro; A Sykes; C M Ferrario
Journal:  Hypertension       Date:  1998-01       Impact factor: 10.190

4.  Renal and antihypertensive effects of neutral endopeptidase inhibition in transgenic rats with an extra renin gene.

Authors:  J P Stasch; C Hirth-Dietrich; D Ganten; M Wegner
Journal:  Am J Hypertens       Date:  1996-08       Impact factor: 2.689

Review 5.  Is there an internal cardiac renin-angiotensin system?

Authors:  A H Danser; M A Schalekamp
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

6.  Estrogen replacement raises rat CRP without evidence of complement activation.

Authors:  S X Yang; N Diaz Padilla; Q Zhu; X M Ma; D Sasso; K Prestwood; C E Hack; G A Kuchel
Journal:  Endocr Res       Date:  2005       Impact factor: 1.720

7.  Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS.

Authors:  K B Brosnihan; P Li; D Ganten; C M Ferrario
Journal:  Am J Physiol       Date:  1997-12

8.  Developmental studies demonstrate age-dependent elevation of renin activity in TGR(mRen2)27 rats.

Authors:  M Véniant; C E Whitworth; J Ménard; M G Sharp; M F Gonzales; P Bruneval; J J Mullins
Journal:  Am J Hypertens       Date:  1995-12       Impact factor: 2.689

9.  Angiotensin and bradykinin peptides in the TGR(mRen-2)27 rat.

Authors:  D J Campbell; P Rong; A Kladis; B Rees; D Ganten; S L Skinner
Journal:  Hypertension       Date:  1995-05       Impact factor: 10.190

10.  Estrogen modulates AT1 receptor gene expression in vitro and in vivo.

Authors:  G Nickenig; A T Bäumer; C Grohè; S Kahlert; K Strehlow; S Rosenkranz; A Stäblein; F Beckers; J F Smits; M J Daemen; H Vetter; M Böhm
Journal:  Circulation       Date:  1998-06-09       Impact factor: 29.690

View more
  61 in total

1.  Amelioration of renal injury and oxidative stress by the nNOS inhibitor L-VNIO in the salt-sensitive mRen2.Lewis congenic rat.

Authors:  Liliya M Yamaleyeva; Sarah H Lindsey; Jasmina Varagic; Li Li Zhang; Patricia E Gallagher; Alex F Chen; Mark C Chappell
Journal:  J Cardiovasc Pharmacol       Date:  2012-06       Impact factor: 3.105

2.  Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).

Authors:  Carlos M Ferrario; Sarfaraz Ahmad; Janae Joyner; Jasmina Varagic
Journal:  Adv Pharmacol       Date:  2010

Review 3.  ACE2: more of Ang-(1-7) or less Ang II?

Authors:  Carlos M Ferrario
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-01       Impact factor: 2.894

4.  Hypersensitivity to acute ANG II in female growth-restricted offspring is exacerbated by ovariectomy.

Authors:  Norma B Ojeda; Suttira Intapad; Thomas P Royals; Joshua T Black; John Henry Dasinger; F Lee Tull; Barbara T Alexander
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-10       Impact factor: 3.619

Review 5.  Molecular mechanisms and regulation of urinary acidification.

Authors:  Ira Kurtz
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

6.  Understanding sex differences in long-term blood pressure regulation: insights from experimental studies and computational modeling.

Authors:  Sameed Ahmed; Rui Hu; Jessica Leete; Anita T Layton
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-03-15       Impact factor: 4.733

7.  Reduced vasorelaxation to estradiol and G-1 in aged female and adult male rats is associated with GPR30 downregulation.

Authors:  Sarah H Lindsey; Ariel S da Silva; Mauro S Silva; Mark C Chappell
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-05-14       Impact factor: 4.310

8.  Interactions between oestrogen and the renin angiotensin system - potential mechanisms for gender differences in Alzheimer's disease.

Authors:  Thomas Simon O'Hagan; Whitney Wharton; Patrick Gavin Kehoe
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

9.  Does ACE2 contribute to the development of hypertension?

Authors:  Mark C Chappell
Journal:  Hypertens Res       Date:  2009-12-18       Impact factor: 3.872

10.  Nuclear expression of renin-angiotensin system components in NRK-52E renal epithelial cells.

Authors:  Ebaa M Alzayadneh; Mark C Chappell
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2014-06-24       Impact factor: 1.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.